Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma

Pancreatic acinar cell carcinoma (ACC) is a rare tumor entity with an unfavorable prognosis. Recent whole-exome sequencing identified p53 mutations in a subset of human ACC. Activation of the mammalian target of rapamycin (mTOR) pathway is associated with various pancreatic neoplasms. We thus aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Kong, Bo (Author) , Cheng, Tao (Author) , Qian, Chengjia (Author) , Wu, Weiwei (Author) , Steiger, Katja (Author) , Cao, Jing (Author) , Schlitter, Anna Melissa (Author) , Regel, Ivonne (Author) , Raulefs, Susanne (Author) , Friess, Helmut (Author) , Erkan, Mert (Author) , Esposito, Irene (Author) , Kleeff, Jörg H. (Author) , Michalski, Christoph (Author)
Format: Article (Journal)
Language:English
Published: 18 December 2015
In: Molecular cancer
Year: 2015, Volume: 14, Issue: 1
ISSN:1476-4598
DOI:10.1186/s12943-015-0483-1
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12943-015-0483-1
Verlag, lizenzpflichtig, Volltext: https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0483-1
Get full text
Author Notes:Bo Kong, Tao Cheng, Chengjia Qian, Weiwei Wu, Katja Steiger, Jing Cao, Anna Melissa Schlitter, Ivonne Regel, Susanne Raulefs, Helmut Friess, Mert Erkan, Irene Esposito, Jörg Kleeff and Christoph W. Michalski
Description
Summary:Pancreatic acinar cell carcinoma (ACC) is a rare tumor entity with an unfavorable prognosis. Recent whole-exome sequencing identified p53 mutations in a subset of human ACC. Activation of the mammalian target of rapamycin (mTOR) pathway is associated with various pancreatic neoplasms. We thus aimed at analyzing whether activation of mTOR with a concomitant loss of p53 may initiate ACC.
Item Description:Gesehen am 15.07.2020
Physical Description:Online Resource
ISSN:1476-4598
DOI:10.1186/s12943-015-0483-1